Conclusion
In conclusion, we found that atorvastatin therapy has positive effects on the course of hospitalization in patients with severe COVID-19. Mostly these effects were seen in important outcomes of these patients i.e., mortality rate, duration of hospitalization, and needs for mechanical ventilation due to COVID-19. Prospective randomized controlled trials are to be recommended to confirm the effect of statins on patients with viral infections, especially severe COVID-19.